Elon Musk’s brain implant company Neuralink says it has received approval from US regulators to begin testing its device on humans.The company made the announcement on Twitter, but has provided no details about a potential study, which was not listed on the US government database of clinical trials.
Officials with the Food and Drug Administration wouldn’t confirm or deny whether the agency granted the approval, but press officer Carly Kempler said in an email that the FDA “acknowledges and understands” that Musk’s company made the announcement.describing an implant that restores communication between the brain and spinal cord to help a man with paralysis to stand and walk naturally. There are more than 30 brain or spine computer interface trials underway, according to clinicaltrials.gov.
Musk has said the first two applications in people would be to attempt to restore vision and try to help people with little or no ability to operate their muscles rapidly use digital devices. He also said he envisions that signals from the brain could be bridged to Neuralink devices in the spinal cord for someone with a broken neck.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: GuardianAus - 🏆 1. / 98 Read more »